About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Cyclophotocoagulation in Glaucoma

NCT02875158·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

CHU de Quebec-Universite Laval

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Patients with poorly controlled high pressure glaucoma
Cyclophotocoagulation necessary to prevent visual loss
Cyclophotocoagulation necessary to prevent or to reduce ocular discomfort

You may not be if

Patient has already undergone a cyclophotocoagulation or cryotherapy treatment in the same eye for glaucoma
Patients receiving concomitant treatment the same day as the intervention
Patient not able to follow the prescribed post-operative treatment

The record

StatusCompleted

PhaseNo phase

Taking part44

StartedAug 2016

UpdatedSep 11, 2023

Conditions

Where1

Centre universitaire d'ophtalmologie, Hôpital du Saint-Sacrement. CHU de Québec
Québec, Canada

Clareo Health | Cyclophotocoagulation in Glaucoma